SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-026427
Filing Date
2022-11-09
Accepted
2022-11-08 18:04:06
Documents
71
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vxrt20220930_10q.htm   iXBRL 10-Q 1403042
2 EXHIBIT 31.1 ex_418674.htm EX-31.1 16831
3 EXHIBIT 31.2 ex_418675.htm EX-31.2 17074
4 EXHIBIT 32.1 ex_418676.htm EX-32.1 13100
10 pipeline2022q2.jpg GRAPHIC 1221338
  Complete submission text file 0001437749-22-026427.txt   8943018

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20220930.xsd EX-101.SCH 59834
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vxrt-20220930_cal.xml EX-101.CAL 44803
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20220930_def.xml EX-101.DEF 401548
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20220930_lab.xml EX-101.LAB 358400
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20220930_pre.xml EX-101.PRE 429054
65 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20220930_10q_htm.xml XML 1090293
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35285 | Film No.: 221370200
SIC: 2836 Biological Products, (No Diagnostic Substances)